IMDX Earnings & Financial Statements
Insight Molecular Diagnostics Inc.
$3.06
+$0.27(+9.68%)
34
Overall
40
Value
18
Tech
44
Quality
Market Cap
$91.30M
Volume
177.68K
52W Range
$2.42 - $8.51
Target Price
$8.33
IMDX earnings and financial statements: Insight Molecular Diagnostics Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
IMDX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $4.05M | $1.88M | $1.50M | $958.0K | $2.20M |
| Cost of revenue | $1.75M | $1.05M | $1.00M | $880.0K | $778.0K |
| Operating income | -$51.12M | -$61.04M | -$25.14M | -$18.00M | -$53.73M |
| EBITDA | -$48.09M | -$59.10M | -$17.26M | -$13.31M | -$48.46M |
| Net income | -$50.22M | -$60.66M | -$27.78M | -$72.90M | -$64.10M |
| EPS (diluted) | $-1.65 | $-4.66 | $-3.75 | $-26.40 | $-14.40 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $25.76M | $35.08M | $74.89M | $100.09M | $159.56M |
| Total liabilities | $57.22M | $47.35M | $49.30M | $60.50M | $94.35M |
| Shareholders’ equity | -$31.46M | -$12.27M | $20.47M | $34.29M | $65.22M |
| Cash and equivalents | $11.60M | $8.64M | $9.43M | $19.99M | $32.95M |
| Long-term debt | - | $2.37M | - | - | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$22.18M | -$20.69M | -$23.32M | -$45.57M | -$35.94M |
| Capital expenditure | -$3.19M | -$512.0K | -$281.0K | -$4.34M | -$2.25M |
| Free cash flow | -$25.37M | -$21.20M | -$23.61M | -$49.91M | -$38.19M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMDX | $3.06 | +9.7% | 177.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Insight Molecular Diagnostics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW